| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Genetic Medicine and Development (P.R., N.L.-M., E.H., J.-C.I., P.A.H.) and Cellular Physiology and Metabolism (F.C.), University Medical Center, 1211 Geneva, Switzerland; and Division of Endocrinology and Diabetes (J.A.E., M.B.-S., M.Y.D.), University Hospital of Zürich, 8091 Zürich, Switzerland
Address all correspondence and requests for reprints to: Dr. Pascale Ribaux, Department of Genetic Medicine and Development, University Medical Center, 1 Michel-Servet Street, 1211 Geneva-4, Switzerland. E-mail: Pascale.Ribaux{at}medecine.unige.ch.
As we showed previously, the extracellular matrix (ECM) derived from rat bladder carcinoma cells (804G-ECM) has positive effects on rat primary β-cell function and survival in vitro. The aim of this study was to define β-cell genes induced by this ECM with a specific focus on cytokines. Analysis of differential gene expression by oligonucleotide microarrays, RT-PCR, and in situ hybridization was performed to identify cytokine mRNA induced by this matrix. Four cytokines were overexpressed on 804G-ECM compared with poly-L-lysine: C-X-C motif ligand 1 (CXCL1), CXCL2, interferon-inducible protein-10, and IL-1β. A time-course experiment indicated that maximal induction by 804G-ECM of CXCL1/2 and interferon-inducible protein-10 occurred at 4 h. Stimulation of CXCL1 release by β-cells on 804G-ECM was confirmed at the protein level. Moreover, secreted CXCL1 was shown to be functionally active by attracting rat granulocytes. Preventing the interaction of β1 integrins and laminin-5 (a major component of 804G-ECM) with specific antibodies resulted in a 40–50% inhibition of CXCL1 expression. Using the nuclear factor-
B pathway inhibitor Bay 11–7082 it is demonstrated that CXCL1 expression and secretion are dependent on nuclear factor-
B activation. IL-1 secreted by β-cells plated on 804G-ECM was found to be a key soluble mediator because treatment of cells with the IL-1 receptor antagonist significantly reduced both CXCL1 gene expression and secretion. It is concluded that ECM induces expression of cytokines including CXCL1 with amplification by IL-1 acting via a positive autocrine feedback loop.
This article has been cited by other articles:
![]() |
M. Boni-Schnetzler, S. Boller, S. Debray, K. Bouzakri, D. T. Meier, R. Prazak, J. Kerr-Conte, F. Pattou, J. A. Ehses, F. C. Schuit, et al. Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I Endocrinology, December 1, 2009; 150(12): 5218 - 5229. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bouzakri, P. Ribaux, and P. A. Halban Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-{alpha}-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion J. Biol. Chem., October 9, 2009; 284(41): 27892 - 27898. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Parnaud, E. Hammar, P. Ribaux, M. Y. Donath, T. Berney, and P. A. Halban Signaling Pathways Implicated in the Stimulation of {beta}-Cell Proliferation by Extracellular Matrix Mol. Endocrinol., August 1, 2009; 23(8): 1264 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boni-Schnetzler, J. Thorne, G. Parnaud, L. Marselli, J. A. Ehses, J. Kerr-Conte, F. Pattou, P. A. Halban, G. C. Weir, and M. Y. Donath Increased Interleukin (IL)-1{beta} Messenger Ribonucleic Acid Expression in {beta}-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1{beta} in Human Islets by Glucose and Autostimulation J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4065 - 4074. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bouzakri, P. Ribaux, A. Tomas, G. Parnaud, K. Rickenbach, and P. A. Halban Rab GTPase-Activating Protein AS160 Is a Major Downstream Effector of Protein Kinase B/Akt Signaling in Pancreatic {beta}-Cells Diabetes, May 1, 2008; 57(5): 1195 - 1204. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |